Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Permissive HLA-DPB1 Mismatching Compared to a Non-Permissive Mismatching Significantly Improves Overall Survival Following Allogeneic Transplantation In Patients with Both 10/10 and 9/10 Matched Unrelated Donors

Bronwen E. Shaw, PhD, MRCP, FRCPath, Katharina Fleischhauer, PhD, Mari Malkki, Theodore Gooley, PhD, Elisabetta Zino, PhD, Stephen Spellman, PhD, Yasuo Morishima, MD, Andrea Velardi, MD, PhD, Peter Bardy, MD, Jean-denis Bignon, J. Alejandro Madrigal, MD, PhD, Effie W. Petersdorf, MD

Blood (2010) 116 (21): 227.

https://doi.org/10.1182/blood.V116.21.227.227

Published: 2010

Journal Articles

Outcome of Hematopoietic Cell Transplant from HLA-Matched Siblings Compared to a Volunteer Unrelated Donors Matched for HLA-A, B, C, DRB1, and DQB1 Alleles.

Ann Woolfrey, MD, Theodore Gooley, PhD, Mari Malkki, John A. Hansen, MD, Paul J. Martin, MD, Stephanie J. Lee, MD, Frederick R. Appelbaum, MD, John M. Pagel, MD, Effie W. Petersdorf, MD

Blood (2007) 110 (11): 170.

https://doi.org/10.1182/blood.V110.11.170.170

Published: 2007

Journal Articles

DLA-Haploidentical Stem Cell Allografts after Anti-CD44 Therapy and Nonmyeloablative Conditioning: The Impact of Donor Lymphocyte Infusion (DLI), Pentostatin and Graft Composition on Donor Chimerism and Rejection.

Fabio Kerbauy, MD, Takahiro Fukuda, MD, Theodore Gooley, PhD, Erlinda B. Santos, Hilary Stempel, Rainer Storb, MD, Brenda M. Sandmaier, MD

Blood (2005) 106 (11): 2194.

https://doi.org/10.1182/blood.V106.11.2194.2194

Published: 2005

Journal Articles

High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc): Long-Term Survivors Show Continued Improvement of Function and Skin with Stability in the Lungs.

Peter McSweeney, MD, Daniel Furst, MD, Leslie Crofford, MD, Kevin McDonagh, MD, Keith Sullivan, MD, Mayes Maureen, MD, Nelson Lee, MD, Theodore Gooley, Ph.D., Jan Storek, MD, PhD, Leona Holmberg, MD, PhD, C.S. Chen, MD, PhD, Mark Wener, MD, Julie Lee, RN, Gretchen Henstorf, CCRC, Muneer Abidi, MD, Philip Mease, MD, Richard Nash, MD

Blood (2004) 104 (11): 149.

https://doi.org/10.1182/blood.V104.11.149.149

Published: 2004

Journal Articles

A humanized non–FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

Paul A. Carpenter, Frederick R. Appelbaum, Lawrence Corey, H. Joachim Deeg, Kris Doney, Theodore Gooley, James Krueger, Paul Martin, Sandra Pavlovic, Jean Sanders, John Slattery, Daniel Levitt, Rainer Storb, Ann Woolfrey, Claudio Anasetti

Blood (2002) 99 (8): 2712–2719.

https://doi.org/10.1182/blood.V99.8.2712

Published: 2002

Journal Articles

CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantation

J. Maciej Zaucha, Theodore Gooley, William I. Bensinger, Shelly Heimfeld, Thomas R. Chauncey, Renata Zaucha, Paul J. Martin, Mary E. D. Flowers, Jan Storek, George Georges, Rainer Storb, Beverly Torok-Storb

Blood (2001) 98 (12): 3221–3227.

https://doi.org/10.1182/blood.V98.12.3221

Published: 2001

Journal Articles

Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes

George E. Georges, Rainer Storb, Benedetto Bruno, Scott J. Brodie, Jennifer D. Thompson, Anna G. Taranova, J. Maciej Zaucha, Marie-Térèse Little, Eustacia Zellmer, Peter F. Moore, Theodore Gooley, George Sale, Hans-Peter Kiem, Brenda M. Sandmaier, Russette M. Lyons, Richard A. Nash

Blood (2001) 98 (12): 3447–3455.

https://doi.org/10.1182/blood.V98.12.3447

Published: 2001

NARROW

Permissive HLA-DPB1 Mismatching Compared to a Non-Permissive Mismatching Significantly Improves Overall Survival Following Allogeneic Transplantation In Patients with Both 10/10 and 9/10 Matched Unrelated Donors

Outcome of Hematopoietic Cell Transplant from HLA-Matched Siblings Compared to a Volunteer Unrelated Donors Matched for HLA-A, B, C, DRB1, and DQB1 Alleles.

DLA-Haploidentical Stem Cell Allografts after Anti-CD44 Therapy and Nonmyeloablative Conditioning: The Impact of Donor Lymphocyte Infusion (DLI), Pentostatin and Graft Composition on Donor Chimerism and Rejection.

High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc): Long-Term Survivors Show Continued Improvement of Function and Skin with Stability in the Lungs.

A humanized non–FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantation

Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes

Email alerts

ASH Publications

American Society of Hematology

Permissive HLA-DPB1 Mismatching Compared to a Non-Permissive Mismatching Significantly Improves Overall Survival Following Allogeneic Transplantation In Patients with Both 10/10 and 9/10 Matched Unrelated Donors

Outcome of Hematopoietic Cell Transplant from HLA-Matched Siblings Compared to a Volunteer Unrelated Donors Matched for HLA-A, B, C, DRB1, and DQB1 Alleles.

DLA-Haploidentical Stem Cell Allografts after Anti-CD44 Therapy and Nonmyeloablative Conditioning: The Impact of Donor Lymphocyte Infusion (DLI), Pentostatin and Graft Composition on Donor Chimerism and Rejection.

High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc): Long-Term Survivors Show Continued Improvement of Function and Skin with Stability in the Lungs.

A humanized non–FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantation

Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only